申请人:AQUINNAH PHARMACEUTICALS, INC.
公开号:US20170088515A1
公开(公告)日:2017-03-30
Herein, compounds and compositions for use in treating diseases relating to inclusion formation and stress granules are described. Methods for screening for modulation of TDP-43 aggregation are also described.